Results mixed on Merck's new painkiller (AP)
AP - The first published studies of Arcoxia the drug that Merck & Co. hopes will take the place of its withdrawn painkiller Vioxx are getting mixed reviews from doctors some of whom say the results do not make a case for the medication's approval.
posted by Smile Community @ 8:09 AM
0 Comments:
Post a Comment
<< Home